Ocumension Therapeutics is a China-based ophthalmic pharmaceutical platform company dedicated to identifying, developing and commercializing first- or best-in-class ophthalmic therapies. Our vision is to provide a world-class pharmaceutical total solution to address significant unmet ophthalmic medical needs in China. Since our inception, we have focused on building a platform integrating specialized capabilities in each major functionality involved in an ophthalmic drug’s development cycle, from research and development, manufacturing to commercialization. We believe our platform positions us well to achieve leadership in China ophthalmology, with a first-mover advantage over future competitors.
To provide Chinese ophthalmic patients with excellent and comprehensive treatment solutions through continuous scientific research and innovation.